Talgar Abilov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Talgar Abilov has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Gulmira Maratovna Iztleuova
West Kazakhstan Marat Ospanov Medical University
4 shared publications - Yerbolat Iztleuov
West Kazakhstan Marat Ospanov Medical University
4 shared publications - R. Irmekbayev
West Kazakhstan Marat Ospanov Medical University
2 shared publications - Ye. Muratov
West Kazakhstan Marat Ospanov Medical University
2 shared publications - A.K. Shotpakova
Marat Ospanov West Kazakhstan Medical University, Aktobe, Republic of Kazakhstan
1 shared publication - Elyanora Kydyrbayeva
«Marat Ospanov West Kazakhstan Medical University» NCJSC
1 shared publication
Latest Publications
- Open Access
- 15 September 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 15 (1) , e12795
The role of intestinal microbiota in the pathogenesis of nephropathy in patients with metabolic syndrome; a systematic review
Introduction: The gut microbiota plays a vital role in maintaining metabolic and renal health. Dysbiosis associated with metabolic syndrome contributes to the development of nephropathy through mechanisms involving inflammation and the production of uremic toxins. Objectives: This study aims to examine the role of the intestinal microbiota in the onset and progression of nephropathy in patients with metabolic syndrome, particularly its impact on renal function. Methods: A systematic review was conducted covering the period from 2020 to 2025, following PRISMA guidelines. Relevant literature on gut microbiota, nephropathy, and metabolic syndrome was identified through databases including Scopus, Web of Science, Cochrane Library, PubMed, and Europe PMC. The quality of included studies was assessed using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale to ensure methodological rigor. Results: The 16 included studies varied in design, study populations, and duration. All reported a reduction in microbial diversity among patients with chronic kidney disease (CKD) and nephropathy. The presence of Prevotella and Faecalibacterium was generally associated with improved kidney function, whereas disease progression correlated with higher levels of Proteobacteria and Clostridium. Metabolites such as indoxyl sulfate and p-cresol glucuronide were commonly linked to nephropathy. Interventions such as probiotic supplementation, fecal microbiota transplantation (FMT), and time-restricted feeding (TRF) showed potential in stabilizing the estimated glomerular filtration rate, reducing uremic toxins, and slowing disease progression. Conclusion: The gut microbiota and its metabolites significantly influence the development and progression of nephropathy in the context of metabolic syndrome. Modulating microbial composition through probiotics and dietary interventions may help restore renal function and mitigate disease advancement. Registration: This review was conducted in accordance with the PRISMA checklist, and the protocol was registered with PROSPERO (ID: CRD420251053100).
- 15 September 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 15 (1) , e12795
Open AccessThe role of intestinal microbiota in the pathogenesis of nephropathy in patients with metabolic syndrome; a systematic review
Introduction: The gut microbiota plays a vital role in maintaining metabolic and renal health. Dysbiosis associated with metabolic syndrome contributes to the development of nephropathy through mechanisms involving inflammation and the production of uremic toxins. Objectives: This study aims to examine the role of the intestinal microbiota in the onset and progression of nephropathy in patients with metabolic syndrome, particularly its impact on renal function. Methods: A systematic review was conducted covering the period from 2020 to 2025, following PRISMA guidelines. Relevant literature on gut microbiota, nephropathy, and metabolic syndrome was identified through databases including Scopus, Web of Science, Cochrane Library, PubMed, and Europe PMC. The quality of included studies was assessed using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale to ensure methodological rigor. Results: The 16 included studies varied in design, study populations, and duration. All reported a reduction in microbial diversity among patients with chronic kidney disease (CKD) and nephropathy. The presence of Prevotella and Faecalibacterium was generally associated with improved kidney function, whereas disease progression correlated with higher levels of Proteobacteria and Clostridium. Metabolites such as indoxyl sulfate and p-cresol glucuronide were commonly linked to nephropathy. Interventions such as probiotic supplementation, fecal microbiota transplantation (FMT), and time-restricted feeding (TRF) showed potential in stabilizing the estimated glomerular filtration rate, reducing uremic toxins, and slowing disease progression. Conclusion: The gut microbiota and its metabolites significantly influence the development and progression of nephropathy in the context of metabolic syndrome. Modulating microbial composition through probiotics and dietary interventions may help restore renal function and mitigate disease advancement. Registration: This review was conducted in accordance with the PRISMA checklist, and the protocol was registered with PROSPERO (ID: CRD420251053100).
- Open Access
- 1 August 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (8) , 423-436
Prevention of Chromium-Induced Radiation-Chemical Oncogenesis, Including in Offspring, in an Experimental Model: A Systematic Review
Radiation and chemical-induced cancer are of increasing concern as the various activities of humans continuously elevate the levels of radiation and toxic chemicals in the environment. The prevention of this incidence using alternative medicines-phytopreparations, therefore, becomes pertinent as conventional approaches tend to produce various unwanted side effects. To achieve this, there is a need to understand the various mechanisms of action through which phytopreparations exhibit their protective effects. This systematic review, therefore, aims to explore the mechanism of action of various phytopreparations in the prevention of induced radiation and chemical (chromium) cancer. A systematic review approach following the stipulated guidelines by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used to identify research papers published between 2015 and 2025. Four databases, namely Europe PubMed Central (PMC), PubMed, Springer Open, and Wiley Online Library were used to search for related open access papers. A total of 621 research papers were reviewed for suitability to the review objective; however, only five papers met the inclusion criteria, and an additional two papers were sourced from ResearchGate. Thus, a total of seven papers were finally included in the analysis. This review highlights the mechanisms of action of various phytopreparations in the prevention of radiation and chromium-induced cancer. The major mechanisms of phytopreparations’ action in the prevention of induced radiation and chromium oncogenesis majorly involve regulating pro and anti-inflammatory cytokines, improving cell-to-cell communication, and preventing damage to DNA structure.
- 1 August 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (8) , 423-436
Open AccessPrevention of Chromium-Induced Radiation-Chemical Oncogenesis, Including in Offspring, in an Experimental Model: A Systematic Review
Radiation and chemical-induced cancer are of increasing concern as the various activities of humans continuously elevate the levels of radiation and toxic chemicals in the environment. The prevention of this incidence using alternative medicines-phytopreparations, therefore, becomes pertinent as conventional approaches tend to produce various unwanted side effects. To achieve this, there is a need to understand the various mechanisms of action through which phytopreparations exhibit their protective effects. This systematic review, therefore, aims to explore the mechanism of action of various phytopreparations in the prevention of induced radiation and chemical (chromium) cancer. A systematic review approach following the stipulated guidelines by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used to identify research papers published between 2015 and 2025. Four databases, namely Europe PubMed Central (PMC), PubMed, Springer Open, and Wiley Online Library were used to search for related open access papers. A total of 621 research papers were reviewed for suitability to the review objective; however, only five papers met the inclusion criteria, and an additional two papers were sourced from ResearchGate. Thus, a total of seven papers were finally included in the analysis. This review highlights the mechanisms of action of various phytopreparations in the prevention of radiation and chromium-induced cancer. The major mechanisms of phytopreparations’ action in the prevention of induced radiation and chromium oncogenesis majorly involve regulating pro and anti-inflammatory cytokines, improving cell-to-cell communication, and preventing damage to DNA structure.
- Open Access
- 15 April 2025
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 75 (1) , 26-33
DYNAMIC ASSESSMENT OF QUALITY OF LIFE ASSOCIATED WITH VISUAL IMPAIRMENT IN PATIENTS RECEIVING CHEMOTHERAPY
Introduction: Chemotherapy and targeted therapy used in cancer treatment are often associated with side effects that affect visual function. Such complications include dry eye syndrome, cataracts, keratopathy, and retinopathy, which can significantly worsen patients’ quality of life. This work focuses on assessing the quality of life of cancer patients experiencing visual impairment and the importance of monitoring these side effects.The study aimed to explore the quality of life of cancer patients with visual impairments resulting from exposure to chemotherapy and targeted therapy, with special attention to the timing of visual complications, their severity, and reversibility.Methods: The study analyzed 65 scientific articles in Russian and English published in PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar databases from 2012 to 2024. The search used keywords related to chemotherapy, toxic effects on vision, and malignant neoplasms. The study included meta-analyses, systematic reviews, controlled clinical trials, and individual case reports.Results: Chemotherapeutic drugs such as cisplatin and paclitaxel cause visual impairment, including dry eye syndrome, red eyes, cataracts, and retinopathy. Targeted drugs such as bevacizumab and erlotinib cause corneal damage, conjunctivitis, and uveitis. Visual impairment significantly worsens patients’ quality of life, creating difficulties in performing everyday tasks such as reading, driving, and recognizing faces. These impairments also cause discomfort, dry eyes, and lacrimation and can lead to decreased visual acuity. In rare cases, the consequences of such impairments lead to partial or complete loss of vision, which seriously affects the patient’s social functioning and emotional state. The use of special ophthalmological questionnaires allows for the early detection of side effects, which helps improve patients’ quality of life.Conclusion: Dynamic quality of life assessment represents a promising approach to understanding and addressing visual impairment in patients receiving chemotherapy and targeted therapy. These methods consider temporal variations and contextual factors that influence quality of life, opening the way for personalized interventions that may improve treatment outcomes.
- 15 April 2025
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 75 (1) , 26-33
Open AccessDYNAMIC ASSESSMENT OF QUALITY OF LIFE ASSOCIATED WITH VISUAL IMPAIRMENT IN PATIENTS RECEIVING CHEMOTHERAPY
Introduction: Chemotherapy and targeted therapy used in cancer treatment are often associated with side effects that affect visual function. Such complications include dry eye syndrome, cataracts, keratopathy, and retinopathy, which can significantly worsen patients’ quality of life. This work focuses on assessing the quality of life of cancer patients experiencing visual impairment and the importance of monitoring these side effects.The study aimed to explore the quality of life of cancer patients with visual impairments resulting from exposure to chemotherapy and targeted therapy, with special attention to the timing of visual complications, their severity, and reversibility.Methods: The study analyzed 65 scientific articles in Russian and English published in PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar databases from 2012 to 2024. The search used keywords related to chemotherapy, toxic effects on vision, and malignant neoplasms. The study included meta-analyses, systematic reviews, controlled clinical trials, and individual case reports.Results: Chemotherapeutic drugs such as cisplatin and paclitaxel cause visual impairment, including dry eye syndrome, red eyes, cataracts, and retinopathy. Targeted drugs such as bevacizumab and erlotinib cause corneal damage, conjunctivitis, and uveitis. Visual impairment significantly worsens patients’ quality of life, creating difficulties in performing everyday tasks such as reading, driving, and recognizing faces. These impairments also cause discomfort, dry eyes, and lacrimation and can lead to decreased visual acuity. In rare cases, the consequences of such impairments lead to partial or complete loss of vision, which seriously affects the patient’s social functioning and emotional state. The use of special ophthalmological questionnaires allows for the early detection of side effects, which helps improve patients’ quality of life.Conclusion: Dynamic quality of life assessment represents a promising approach to understanding and addressing visual impairment in patients receiving chemotherapy and targeted therapy. These methods consider temporal variations and contextual factors that influence quality of life, opening the way for personalized interventions that may improve treatment outcomes.
- Open Access
- 31 March 2025
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 75 (1) , 26-33
DYNAMIC ASSESSMENT OF QUALITY OF LIFE ASSOCIATED WITH VISUAL IMPAIRMENT IN PATIENTS RECEIVING CHEMOTHERAPY
Introduction: Chemotherapy and targeted therapy used in the treatment of cancer are often accompanied by side effects that affect visual function. Such complications include dry eye syndrome, cataracts, keratopathy, and retinopathy, which can significantly worsen patients’ quality of life. This work focuses on assessing the quality of life of cancer patients experiencing visual impairment and the importance of monitoring these side effects. Objective: To study the quality of life of cancer patients with visual impairments resulting from exposure to chemotherapy and targeted therapy, with special attention to the timing of visual complications, their severity, and reversibility. Materials and methods: The study analyzed 65 scientific articles in Russian and English published in PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar databases from 2012 to 2024. The search used keywords related to chemotherapy, toxic effects on vision, and malignant neoplasms. The study included meta-analyses, systematic reviews, controlled clinical trials, and individual case reports. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ 34 Онкология и Радиология Казахстана, №1 (75) 2025 Прозрачность исследования: Авторы несут полную ответственность за содержание данной статьи. Конфликт интересов: Авторы заявляют об отсутствии конфликта интересов. Финансирование: работа выполнена в рамках научного проекта с грантовым финансированием Комитета науки Министерства науки и высшего образования Республики Казахстан "АР19678225 Профилактика спонтанного онкогенеза у первого поколения крыс, родители которого подвергались воздействию гамма-облучения и хрома (эксперимент)" (рег. номер 0123РК00613). Вклад авторов: вклад в концепцию – Ирмекбаев Р.М., Изтлеуов Е.М.; научный дизайн – Муратов Е.Т., Изтлеуов Е.М.; исполнение заявленного научного исследования – Изтлеуов Е.М., Муратов Е.Т., Авизова З.К.; интерпретация заявленного научного исследования – Изтлеуов Е.М., Абилов Т.С.; создание научной статьи – Изтлеуов Е.М., Изтлеуова Г.М. Сведения об авторах: Ирмекбаев Р.М. – докторант НАО «ЗКМУ имени Марата Оспанова», ассистент кафедры офтальмологии, Актобе, Республика Казахстан, тел. +77762927416, e-mail: ruslan_xdrive@mail.ru, ORCID: 0009-0004-1138-3884; Изтлеуов Е.М. (корреспондирующий автор) – асс.проф., к.м.н., руководитель кафедры радиологии НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77756988866, e-mail: ermar80@mail.ru, ORCID: 0000-0002-5303-8593; Муратов Е.Т. – докторант НАО «ЗКМУ имени Марата Оспанова», ассистент кафедры офтальмологии, Актобе, Республика Казахстан, тел. 87057670044, e-mail: yesssset@gmail.com, ORCID: 0000-0002-9542-5962; Авизова З.К. – докторант НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77477935005, e-mail: zeinepavizova@gmail.com, ORCID: 0000-0001-5540-0229; Абилов Т.С. – к.м.н., в.и.о. НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел +77022272813; e-mail: abilovtalgar@gmail.com ORCID:0009-0001-8417-7924; Изтлеуова Г.М. – к.м.н., заведующий курсом дерматовенерологии НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77078818666; ORCID: 0000-0002-5695-0895. Адрес для корреспонденции: Изтлеуов Е.М., НАО ЗКМУ имени Марата Оспанова, ул. Маресьева 68, Актобе 030000, Республика Казахстан. Results: Chemotherapeutic drugs such as cisplatin and paclitaxel cause visual impairment, including dry eye syndrome, red eyes, cataracts, and retinopathy. Targeted drugs such as bevacizumab and erlotinib cause corneal damage, conjunctivitis, and uveitis. Visual impairment significantly worsens patients’ quality of life, creating difficulties in performing everyday tasks such as reading, driving, and recognizing faces. These impairments also cause discomfort, dry eyes, and lacrimation and can lead to decreased visual acuity. In rare cases, the consequences of such impairments lead to partial or complete loss of vision, which seriously affects the patient’s social functioning and emotional state. The use of special ophthalmological questionnaires allows for the early detection of side effects, which helps improve patients’ quality of life. Conclusion: Dynamic quality of life assessment represents a promising approach to understanding and addressing visual impairment in patients receiving chemotherapy and targeted therapy. By considering temporal variations and contextual factors that influence quality of life, these methods open the way for personalized interventions that may improve treatment outcomes.
- 31 March 2025
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 75 (1) , 26-33
Open AccessDYNAMIC ASSESSMENT OF QUALITY OF LIFE ASSOCIATED WITH VISUAL IMPAIRMENT IN PATIENTS RECEIVING CHEMOTHERAPY
Introduction: Chemotherapy and targeted therapy used in the treatment of cancer are often accompanied by side effects that affect visual function. Such complications include dry eye syndrome, cataracts, keratopathy, and retinopathy, which can significantly worsen patients’ quality of life. This work focuses on assessing the quality of life of cancer patients experiencing visual impairment and the importance of monitoring these side effects. Objective: To study the quality of life of cancer patients with visual impairments resulting from exposure to chemotherapy and targeted therapy, with special attention to the timing of visual complications, their severity, and reversibility. Materials and methods: The study analyzed 65 scientific articles in Russian and English published in PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar databases from 2012 to 2024. The search used keywords related to chemotherapy, toxic effects on vision, and malignant neoplasms. The study included meta-analyses, systematic reviews, controlled clinical trials, and individual case reports. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ 34 Онкология и Радиология Казахстана, №1 (75) 2025 Прозрачность исследования: Авторы несут полную ответственность за содержание данной статьи. Конфликт интересов: Авторы заявляют об отсутствии конфликта интересов. Финансирование: работа выполнена в рамках научного проекта с грантовым финансированием Комитета науки Министерства науки и высшего образования Республики Казахстан "АР19678225 Профилактика спонтанного онкогенеза у первого поколения крыс, родители которого подвергались воздействию гамма-облучения и хрома (эксперимент)" (рег. номер 0123РК00613). Вклад авторов: вклад в концепцию – Ирмекбаев Р.М., Изтлеуов Е.М.; научный дизайн – Муратов Е.Т., Изтлеуов Е.М.; исполнение заявленного научного исследования – Изтлеуов Е.М., Муратов Е.Т., Авизова З.К.; интерпретация заявленного научного исследования – Изтлеуов Е.М., Абилов Т.С.; создание научной статьи – Изтлеуов Е.М., Изтлеуова Г.М. Сведения об авторах: Ирмекбаев Р.М. – докторант НАО «ЗКМУ имени Марата Оспанова», ассистент кафедры офтальмологии, Актобе, Республика Казахстан, тел. +77762927416, e-mail: ruslan_xdrive@mail.ru, ORCID: 0009-0004-1138-3884; Изтлеуов Е.М. (корреспондирующий автор) – асс.проф., к.м.н., руководитель кафедры радиологии НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77756988866, e-mail: ermar80@mail.ru, ORCID: 0000-0002-5303-8593; Муратов Е.Т. – докторант НАО «ЗКМУ имени Марата Оспанова», ассистент кафедры офтальмологии, Актобе, Республика Казахстан, тел. 87057670044, e-mail: yesssset@gmail.com, ORCID: 0000-0002-9542-5962; Авизова З.К. – докторант НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77477935005, e-mail: zeinepavizova@gmail.com, ORCID: 0000-0001-5540-0229; Абилов Т.С. – к.м.н., в.и.о. НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел +77022272813; e-mail: abilovtalgar@gmail.com ORCID:0009-0001-8417-7924; Изтлеуова Г.М. – к.м.н., заведующий курсом дерматовенерологии НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77078818666; ORCID: 0000-0002-5695-0895. Адрес для корреспонденции: Изтлеуов Е.М., НАО ЗКМУ имени Марата Оспанова, ул. Маресьева 68, Актобе 030000, Республика Казахстан. Results: Chemotherapeutic drugs such as cisplatin and paclitaxel cause visual impairment, including dry eye syndrome, red eyes, cataracts, and retinopathy. Targeted drugs such as bevacizumab and erlotinib cause corneal damage, conjunctivitis, and uveitis. Visual impairment significantly worsens patients’ quality of life, creating difficulties in performing everyday tasks such as reading, driving, and recognizing faces. These impairments also cause discomfort, dry eyes, and lacrimation and can lead to decreased visual acuity. In rare cases, the consequences of such impairments lead to partial or complete loss of vision, which seriously affects the patient’s social functioning and emotional state. The use of special ophthalmological questionnaires allows for the early detection of side effects, which helps improve patients’ quality of life. Conclusion: Dynamic quality of life assessment represents a promising approach to understanding and addressing visual impairment in patients receiving chemotherapy and targeted therapy. By considering temporal variations and contextual factors that influence quality of life, these methods open the way for personalized interventions that may improve treatment outcomes.
- Open Access
- 28 February 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 1(27),p. 174-184
MODERN VIEW ON THE MORPHOFUNCTION OF THE HEART AND INTRACARDIAC NERVOUS STRUCTURES
Introduction. Over the past 10 years, there has been a high mortality rate from cardiovascular system pathologies associated with the autonomic nervous system. Mortality from heart pathology and its complications is mainly observed among the working-age population. At the same time, the relationship between the cardiac conduction system and the autonomic nervous system, as well as their role in regulating the stable functioning of the heart, occupy a significant place in modern scientific hypotheses proposed by a number of researchers. In this regard, research in this area remains highly relevant. Aim: To analyze the scientific literature on the morphofunctional basis of the regulation of cardiac activity and intracardiac nervous structures. Search Strategy: The search for articles was conducted using the databases of PubMed, Google Scholar, Embase, and the Cochrane Library, as well as data from domestic scientific publications. The search covered a 10-year period (2014–2024). A total of 71 scientific publications were analyzed. Results. As a result of the study, explanations are provided regarding the relevance of morphological research on the cardiovascular system, along with modern scientific conclusions on the morphological function of the heart's nervous structures. Conclusion. The significance of morphological structures, including intracardiac nerve plexuses, nodes, and fibers, which play a crucial role in the stable functioning of the heart, has been established. Введение. За последние 10 лет регистрируется высокая смертность от патологий сердечно-сосудистой системы, связанных с вегетативной нервной системой. Смертность от патологии сердца и ее осложнений в основном отмечается среди лиц трудоспособного возраста. При этом взаимосвязь между проводящей системой сердца и автономной нервной системой и их роль в регулировании устойчивой деятельности сердца занимают большое место в современных научных гипотезах целого ряда ученых. В этой связи актуальны исследования в этом направлении. Цель исследования. Анализ научной литературы по вопросу морфофункционального обоснования регуляции сердечной деятельности и внутрисердечных нервных структур. Стратегия поиска. Поиск статей проведен с использованием баз данных поисковых систем PubMed, Google Scholar, Embase, Cochrane Library, а также данных отечественных научных изданий. Глубина поиска 10 лет (2014 - 2024 гг.). Всего было проанализировано 71 научных публикаций. Результаты. В результате анализа литературы обобщены данные об актуальности морфологического исследования сердечно-сосудистой системы, современных научных выводов по морфо-функции нервных структур сердца. Заключение. Определено значение морфологических структур и внутрисердечных нервных сплетений, узлов и волокон, занимающих важное место в стабильном функционировании сердца. Кіріспе. Соңғы 10 жылда вегетативті жүйке жүйесімен байланысты жүрек – тамырлар жүйесінің патологияларынан болатын өлім-жітімнің жоғары деңгейі тіркелуде. Жүрек патологияларынан және оның асқынуларынан болатын өлім-жітім негізінен еңбекке қабілетті жастағы тұлғалардың арасында байқалады. Бұл ретте, жүректің өткізгіш жүйесі мен автономды жүйке жүйесі арасындағы өзара қатынас және жүректің тұрақты қызметінің реттелуіндегі рөлі бірқатар ғалымдардың заманауи ғылыми гипотезаларында үлкен орын алады. Осыған байланысты осы бағыттағы зерттеулер өзекті. Зерттеу мақсаты. Жүрек қызметін реттеу және жүрек ішілік жүйке құрылымдарының морфофункционалдық негізделуі сұрақтары бойынша ғылыми әдебиеттерді талдау. Іздеу стратегиясы. Мақалаларды іздеу PubMed, Google Scholar, Embase, Cochrane Library мәліметтер қоры бойынша, сонымен қатар отандық ғылыми басылымдар мәліметтерін қолдана отырып жүргізілді. Іздеу жылдықты соңғы 10 жыл (2014 – 2024 жж.). Барлығы 71 ғылыми жарияланымдарға талдау жасалды. Нәтижелер. Зерттеу нәтижесінде жүрек – тамырлар жүйесін морфологиялық тұрғыдан зерттеудің өзектілігі, жүректің жүйке құрылымдарының...
- 28 February 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 1(27),p. 174-184
Open AccessMODERN VIEW ON THE MORPHOFUNCTION OF THE HEART AND INTRACARDIAC NERVOUS STRUCTURES
Introduction. Over the past 10 years, there has been a high mortality rate from cardiovascular system pathologies associated with the autonomic nervous system. Mortality from heart pathology and its complications is mainly observed among the working-age population. At the same time, the relationship between the cardiac conduction system and the autonomic nervous system, as well as their role in regulating the stable functioning of the heart, occupy a significant place in modern scientific hypotheses proposed by a number of researchers. In this regard, research in this area remains highly relevant. Aim: To analyze the scientific literature on the morphofunctional basis of the regulation of cardiac activity and intracardiac nervous structures. Search Strategy: The search for articles was conducted using the databases of PubMed, Google Scholar, Embase, and the Cochrane Library, as well as data from domestic scientific publications. The search covered a 10-year period (2014–2024). A total of 71 scientific publications were analyzed. Results. As a result of the study, explanations are provided regarding the relevance of morphological research on the cardiovascular system, along with modern scientific conclusions on the morphological function of the heart's nervous structures. Conclusion. The significance of morphological structures, including intracardiac nerve plexuses, nodes, and fibers, which play a crucial role in the stable functioning of the heart, has been established. Введение. За последние 10 лет регистрируется высокая смертность от патологий сердечно-сосудистой системы, связанных с вегетативной нервной системой. Смертность от патологии сердца и ее осложнений в основном отмечается среди лиц трудоспособного возраста. При этом взаимосвязь между проводящей системой сердца и автономной нервной системой и их роль в регулировании устойчивой деятельности сердца занимают большое место в современных научных гипотезах целого ряда ученых. В этой связи актуальны исследования в этом направлении. Цель исследования. Анализ научной литературы по вопросу морфофункционального обоснования регуляции сердечной деятельности и внутрисердечных нервных структур. Стратегия поиска. Поиск статей проведен с использованием баз данных поисковых систем PubMed, Google Scholar, Embase, Cochrane Library, а также данных отечественных научных изданий. Глубина поиска 10 лет (2014 - 2024 гг.). Всего было проанализировано 71 научных публикаций. Результаты. В результате анализа литературы обобщены данные об актуальности морфологического исследования сердечно-сосудистой системы, современных научных выводов по морфо-функции нервных структур сердца. Заключение. Определено значение морфологических структур и внутрисердечных нервных сплетений, узлов и волокон, занимающих важное место в стабильном функционировании сердца. Кіріспе. Соңғы 10 жылда вегетативті жүйке жүйесімен байланысты жүрек – тамырлар жүйесінің патологияларынан болатын өлім-жітімнің жоғары деңгейі тіркелуде. Жүрек патологияларынан және оның асқынуларынан болатын өлім-жітім негізінен еңбекке қабілетті жастағы тұлғалардың арасында байқалады. Бұл ретте, жүректің өткізгіш жүйесі мен автономды жүйке жүйесі арасындағы өзара қатынас және жүректің тұрақты қызметінің реттелуіндегі рөлі бірқатар ғалымдардың заманауи ғылыми гипотезаларында үлкен орын алады. Осыған байланысты осы бағыттағы зерттеулер өзекті. Зерттеу мақсаты. Жүрек қызметін реттеу және жүрек ішілік жүйке құрылымдарының морфофункционалдық негізделуі сұрақтары бойынша ғылыми әдебиеттерді талдау. Іздеу стратегиясы. Мақалаларды іздеу PubMed, Google Scholar, Embase, Cochrane Library мәліметтер қоры бойынша, сонымен қатар отандық ғылыми басылымдар мәліметтерін қолдана отырып жүргізілді. Іздеу жылдықты соңғы 10 жыл (2014 – 2024 жж.). Барлығы 71 ғылыми жарияланымдарға талдау жасалды. Нәтижелер. Зерттеу нәтижесінде жүрек – тамырлар жүйесін морфологиялық тұрғыдан зерттеудің өзектілігі, жүректің жүйке құрылымдарының...